During the past decade, Kliniken der Stadt Köln gGmbH conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 3 clinical trials were completed, i.e. on average, 17.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kliniken der Stadt Köln gGmbH" #1 sponsor was "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored and "Bioven Europe" with 1 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken der Stadt Köln gGmbH" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "AGO Breast Study Group e.V." with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "B. Braun Melsungen AG" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Kliniken der Stadt Köln gGmbH" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Non Small Cell Lung Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Anaplastic Astrocytoma WHO Grade III" (1 trials) and "Brady Tachy Syndrome" (1 trials). Many other conditions were trialed in "Kliniken der Stadt Köln gGmbH" in a lesser frequency.

Most popular intervention types in "Kliniken der Stadt Köln gGmbH" are "Drug" (19 trials), "Biological" (7 trials), "Radiation" (6 trials), "Procedure" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Placebo" (3 trials), "ifosfamide" (3 trials), "radiation therapy" (3 trials) and "vindesine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken der Stadt Köln gGmbH" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kliniken der Stadt Köln gGmbH". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Kliniken der Stadt Köln gGmbH, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken der Stadt Köln gGmbH, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".

Kliniken der Stadt Köln gGmbH has several departments that took part in Clinical trials: "Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz" - 2 trials